Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Tirrò
Observed names:
E Tirrò,
E. Tirrò,
ELENA TIRRÒ,
ELENA TIRRÓ,
Elena Tirrò,
Elena Tirro’,
Tirro, E
show all 7
Institution:
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco"
Observed institutions:
University of Catania,
Policlinico Universitario di Catania,
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco",
University of Palermo
ORCID:
0000-0001-8012-5134
Observed ORCID:
0000-0001-8012-5134
OpenAlex ID:
A5030170002
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells
2009
·
Cristian Bellodi
, Maria Rosa Lidonnici
, et al.
·
Journal of Clinical Investigation
·
620
The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy
2015
·
Paolo Giovanni Vigneri
, Elena Tirrò
, et al.
·
Frontiers in Oncology
·
204
PDF
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice
2019
·
Elena Tirrò
, Federica Martorana
, et al.
·
Genes
·
111
New Insights in Thyroid Cancer and p53 Family Proteins
2017
·
Livia Manzella
, Stefania Stella
, et al.
·
International Journal of Molecular Sciences
·
107
PDF
Altered Expression of c-IAP1, Survivin, and Smac Contributes to Chemotherapy Resistance in Thyroid Cancer Cells
2006
·
Elena Tirrò
, Maria Letizia Consoli
, et al.
·
Cancer Research
·
107
PDF
FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series
2020
·
Francesco Certo
, Roberto Altieri
, et al.
·
Operative Neurosurgery
·
88
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
2018
·
Michele Massimino
, Stefania Stella
, et al.
·
Molecular Cancer
·
66
PDF
Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment
2019
·
Livia Manzella
, Michele Massimino
, et al.
·
International Journal of Molecular Sciences
·
62
PDF
Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs
2013
·
Stefania Stella
, Elena Tirrò
, et al.
·
Molecular Cancer Therapeutics
·
59
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance
2021
·
Silvia Rita Vitale
, Federica Martorana
, et al.
·
Critical Reviews in Oncology/Hematology
·
53
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
2021
·
Elena Tirrò
, Michele Massimino
, et al.
·
Frontiers in Oncology
·
50
PDF
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives
2020
·
MICHELE MASSIMINO
, STEFANIA STELLA
, et al.
·
Anticancer Research
·
44
PDF
Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas
2021
·
Giuseppe Broggi
, Lucia Salvatorelli
, et al.
·
Cancers
·
41
PDF
Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia
2016
·
Livia Manzella
, Elena Tirrò
, et al.
·
Current Cancer Drug Targets
·
41
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
2023
·
Veronica Veschi
, Alice Turdo
, et al.
·
Nature Communications
·
37
PDF
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells
2013
·
Cristian Bellodi
, Maria Rosa Lidonnici
, et al.
·
Journal of Clinical Investigation
·
37
PDF
BCR‐ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein
2013
·
Pietro Buffa
, Chiara Romano
, et al.
·
The FASEB Journal
·
36
PDF
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications
2022
·
Elena Tirrò
, Michele Massimino
, et al.
·
Frontiers in Oncology
·
35
Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer
2021
·
Chiara Romano
, Federica Martorana
, et al.
·
International Journal of Molecular Sciences
·
35
PDF
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53
2019
·
Elena Tirrò
, Michele Massimino
, et al.
·
Frontiers in Oncology
·
33
PDF
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation
2014
·
Michele Massimino
, Maria Letizia Consoli
, et al.
·
Carcinogenesis
·
31
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes
2021
·
Stefania Stella
, Michele Massimino
, et al.
·
International Journal of Molecular Sciences
·
26
PDF
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib
2019
·
Stefania Stella
, Valentina Zammit
, et al.
·
International Journal of Molecular Sciences
·
24
PDF
Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells
2018
·
MICHELE MASSIMINO
, ELENA TIRRÒ
, et al.
·
Anticancer Research
·
24
PDF
BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors
2019
·
Maria Stella Pennisi
, Stefania Stella
, et al.
·
Frontiers in Oncology
·
18
PDF
Show more works
View as search
Works count:
61
Citation count:
2,223
H-index:
24
I10-index:
37
Year
Topic
Type